740 related articles for article (PubMed ID: 27064257)
1. Whole-genome mutational landscape and characterization of noncoding and structural mutations in liver cancer.
Fujimoto A; Furuta M; Totoki Y; Tsunoda T; Kato M; Shiraishi Y; Tanaka H; Taniguchi H; Kawakami Y; Ueno M; Gotoh K; Ariizumi S; Wardell CP; Hayami S; Nakamura T; Aikata H; Arihiro K; Boroevich KA; Abe T; Nakano K; Maejima K; Sasaki-Oku A; Ohsawa A; Shibuya T; Nakamura H; Hama N; Hosoda F; Arai Y; Ohashi S; Urushidate T; Nagae G; Yamamoto S; Ueda H; Tatsuno K; Ojima H; Hiraoka N; Okusaka T; Kubo M; Marubashi S; Yamada T; Hirano S; Yamamoto M; Ohdan H; Shimada K; Ishikawa O; Yamaue H; Chayama K; Miyano S; Aburatani H; Shibata T; Nakagawa H
Nat Genet; 2016 May; 48(5):500-9. PubMed ID: 27064257
[TBL] [Abstract][Full Text] [Related]
2. Integrated analysis of whole genome and transcriptome sequencing reveals diverse transcriptomic aberrations driven by somatic genomic changes in liver cancers.
Shiraishi Y; Fujimoto A; Furuta M; Tanaka H; Chiba K; Boroevich KA; Abe T; Kawakami Y; Ueno M; Gotoh K; Ariizumi S; Shibuya T; Nakano K; Sasaki A; Maejima K; Kitada R; Hayami S; Shigekawa Y; Marubashi S; Yamada T; Kubo M; Ishikawa O; Aikata H; Arihiro K; Ohdan H; Yamamoto M; Yamaue H; Chayama K; Tsunoda T; Miyano S; Nakagawa H
PLoS One; 2014; 9(12):e114263. PubMed ID: 25526364
[TBL] [Abstract][Full Text] [Related]
3. Genome sequencing analysis of liver cancer for precision medicine.
Nakagawa H; Fujita M; Fujimoto A
Semin Cancer Biol; 2019 Apr; 55():120-127. PubMed ID: 29605648
[TBL] [Abstract][Full Text] [Related]
4. Identification of coding and non-coding mutational hotspots in cancer genomes.
Piraino SW; Furney SJ
BMC Genomics; 2017 Jan; 18(1):17. PubMed ID: 28056774
[TBL] [Abstract][Full Text] [Related]
5. LARVA: an integrative framework for large-scale analysis of recurrent variants in noncoding annotations.
Lochovsky L; Zhang J; Fu Y; Khurana E; Gerstein M
Nucleic Acids Res; 2015 Sep; 43(17):8123-34. PubMed ID: 26304545
[TBL] [Abstract][Full Text] [Related]
6. A Significant Regulatory Mutation Burden at a High-Affinity Position of the CTCF Motif in Gastrointestinal Cancers.
Umer HM; Cavalli M; Dabrowski MJ; Diamanti K; Kruczyk M; Pan G; Komorowski J; Wadelius C
Hum Mutat; 2016 Sep; 37(9):904-13. PubMed ID: 27174533
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive genome sequencing of the liver cancer genome.
Nakagawa H; Shibata T
Cancer Lett; 2013 Nov; 340(2):234-40. PubMed ID: 23142287
[TBL] [Abstract][Full Text] [Related]
8. Next generation sequencing reveals genetic landscape of hepatocellular carcinomas.
Li S; Mao M
Cancer Lett; 2013 Nov; 340(2):247-53. PubMed ID: 23063663
[TBL] [Abstract][Full Text] [Related]
9. IW-Scoring: an Integrative Weighted Scoring framework for annotating and prioritizing genetic variations in the noncoding genome.
Wang J; Dayem Ullah AZ; Chelala C
Nucleic Acids Res; 2018 May; 46(8):e47. PubMed ID: 29390075
[TBL] [Abstract][Full Text] [Related]
10. Cis-regulatory somatic mutations and gene-expression alteration in B-cell lymphomas.
Mathelier A; Lefebvre C; Zhang AW; Arenillas DJ; Ding J; Wasserman WW; Shah SP
Genome Biol; 2015 Apr; 16(1):84. PubMed ID: 25903198
[TBL] [Abstract][Full Text] [Related]
11. CTCF/cohesin-binding sites are frequently mutated in cancer.
Katainen R; Dave K; Pitkänen E; Palin K; Kivioja T; Välimäki N; Gylfe AE; Ristolainen H; Hänninen UA; Cajuso T; Kondelin J; Tanskanen T; Mecklin JP; Järvinen H; Renkonen-Sinisalo L; Lepistö A; Kaasinen E; Kilpivaara O; Tuupanen S; Enge M; Taipale J; Aaltonen LA
Nat Genet; 2015 Jul; 47(7):818-21. PubMed ID: 26053496
[TBL] [Abstract][Full Text] [Related]
12. Altered TERT promoter and other genomic regulatory elements: occurrence and impact.
Heidenreich B; Kumar R
Int J Cancer; 2017 Sep; 141(5):867-876. PubMed ID: 28407294
[TBL] [Abstract][Full Text] [Related]
13. Mutational signatures reveal the dynamic interplay of risk factors and cellular processes during liver tumorigenesis.
Letouzé E; Shinde J; Renault V; Couchy G; Blanc JF; Tubacher E; Bayard Q; Bacq D; Meyer V; Semhoun J; Bioulac-Sage P; Prévôt S; Azoulay D; Paradis V; Imbeaud S; Deleuze JF; Zucman-Rossi J
Nat Commun; 2017 Nov; 8(1):1315. PubMed ID: 29101368
[TBL] [Abstract][Full Text] [Related]
14. Whole-genome sequencing identifies ADGRG6 enhancer mutations and FRS2 duplications as angiogenesis-related drivers in bladder cancer.
Wu S; Ou T; Xing N; Lu J; Wan S; Wang C; Zhang X; Yang F; Huang Y; Cai Z
Nat Commun; 2019 Feb; 10(1):720. PubMed ID: 30755618
[TBL] [Abstract][Full Text] [Related]
15. Candidate Cancer Driver Mutations in Distal Regulatory Elements and Long-Range Chromatin Interaction Networks.
Zhu H; Uusküla-Reimand L; Isaev K; Wadi L; Alizada A; Shuai S; Huang V; Aduluso-Nwaobasi D; Paczkowska M; Abd-Rabbo D; Ocsenas O; Liang M; Thompson JD; Li Y; Ruan L; Krassowski M; Dzneladze I; Simpson JT; Lupien M; Stein LD; Boutros PC; Wilson MD; Reimand J
Mol Cell; 2020 Mar; 77(6):1307-1321.e10. PubMed ID: 31954095
[TBL] [Abstract][Full Text] [Related]
16. Whole genome analysis reveals the genomic complexity in metastatic cutaneous squamous cell carcinoma.
Thind AS; Ashford B; Strbenac D; Mitchell J; Lee J; Mueller SA; Minaei E; Perry JR; Ch'ng S; Iyer NG; Clark JR; Gupta R; Ranson M
Front Oncol; 2022; 12():919118. PubMed ID: 35982973
[TBL] [Abstract][Full Text] [Related]
17. Chromatin structure-based prediction of recurrent noncoding mutations in cancer.
Kim K; Jang K; Yang W; Choi EY; Park SM; Bae M; Kim YJ; Choi JK
Nat Genet; 2016 Nov; 48(11):1321-1326. PubMed ID: 27723759
[TBL] [Abstract][Full Text] [Related]
18. Genomic landscape of copy number aberrations enables the identification of oncogenic drivers in hepatocellular carcinoma.
Wang K; Lim HY; Shi S; Lee J; Deng S; Xie T; Zhu Z; Wang Y; Pocalyko D; Yang WJ; Rejto PA; Mao M; Park CK; Xu J
Hepatology; 2013 Aug; 58(2):706-17. PubMed ID: 23505090
[TBL] [Abstract][Full Text] [Related]
19. Epigenomic annotation of noncoding mutations identifies mutated pathways in primary liver cancer.
Lowdon RF; Wang T
PLoS One; 2017; 12(3):e0174032. PubMed ID: 28333948
[TBL] [Abstract][Full Text] [Related]
20. Whole genome sequencing analysis identifies recurrent structural alterations in esophageal squamous cell carcinoma.
Dutta M; Nakagawa H; Kato H; Maejima K; Sasagawa S; Nakano K; Sasaki-Oku A; Fujimoto A; Mateos RN; Patil A; Tanaka H; Miyano S; Yasuda T; Nakai K; Fujita M
PeerJ; 2020; 8():e9294. PubMed ID: 32617189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
